By Robb M. Stewart
NextGen Healthcare’s rallied in premarket trading after the healthcare technology company agreed to be bought by private-equity firm Thoma Bravo in a deal that values it at about $1.61 billion.
Before the opening bell, the shares were 14% higher after ending Tuesday at $20.55, down 9.4% so far this year.
NextGen said it entered a definitive agreement that will see its shareholders receive $23.95 a share in cash, a 46% premium to the closing price on Aug. 22, before reports of a possible transaction.
“The agreement with Thoma Bravo validates NextGen Healthcare’s substantial strength and follows interest in the company by many parties,” NextGen Chairman Jeffrey Margolis said.
When the deal is completed, NextGen will become a privately held company.
The takeover has been unanimously approved by NextGen’s board and is expected to close before the end of the year, subject to shareholder and regulatory approval.
Write to Robb M. Stewart at [email protected]
Corrections & Amplifications
This article was corrected on Sept. 27, 2023 to show that NextGen Healthcare’s shares ended Tuesday down 9.4% so far this year. The original version incorrectly said the shares were down 82% so far this year.
NextGen Healthcare’s shares ended Tuesday down 9.4% so far this year. “NextGen Healthcare Shares Jump Premarket After Deal With Thoma Bravo,” at 8:04 a.m. ET on Sept. 6, incorrectly said the shares were down 82% so far this year.
Read the full article here